183 related articles for article (PubMed ID: 15497110)
1. [ACE inhibitor therapy until end of life?].
Werner N
Dtsch Med Wochenschr; 2004 Oct; 129(44):2375-6. PubMed ID: 15497110
[No Abstract] [Full Text] [Related]
2. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
3. [ACE inhibitors for diabetic patients. passed the test on the heart and kidneys].
MMW Fortschr Med; 2002 Oct; 144(44):53. PubMed ID: 12494601
[No Abstract] [Full Text] [Related]
4. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
[No Abstract] [Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. [Renal side effects of angiotensin converting enzyme inhibitors].
Schmidt A; Mayer G
Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683
[TBL] [Abstract][Full Text] [Related]
7. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
8. [Ramipril after myocardial infarct. Long lasting cardiovascular protective action].
MMW Fortschr Med; 2003 Sep; 145(39):46. PubMed ID: 14649074
[No Abstract] [Full Text] [Related]
9. [Improved protection of heart and kidneys in the hypertensive patient. ACE inhibitor and AT1 blocker combined?].
MMW Fortschr Med; 2003 Jun; 145(23):59. PubMed ID: 12854231
[No Abstract] [Full Text] [Related]
10. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
11. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
12. [Renal effect of treatment for heart failure].
Rasmussen ZZ; Barfod T; Klit J
Ugeskr Laeger; 2009 Feb; 171(9):718. PubMed ID: 19257999
[TBL] [Abstract][Full Text] [Related]
13. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
Ferrari R; Ambrosio G; Chiariello M
Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
[No Abstract] [Full Text] [Related]
14. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
Kazi D; Deswal A
Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901
[TBL] [Abstract][Full Text] [Related]
15. [New discoveries on target blood pressure and ACE inhibitors. Swedish guidelines on hypertension are still correct].
Ostergren J
Lakartidningen; 1998 Aug; 95(32-33):3380-1. PubMed ID: 9725941
[No Abstract] [Full Text] [Related]
16. Now or never: optimal antihypertensive therapy in the elderly.
Prisant LM
Prev Cardiol; 2008; 11(4):201-9. PubMed ID: 19476572
[TBL] [Abstract][Full Text] [Related]
17. [Ramipril treatment of heart failure in disseminated forms of pulmonary tuberculosis].
Ditiatkov AE; Radzevich AE; Tikhonov VA; Gal' IG
Probl Tuberk; 1999; (2):31-2. PubMed ID: 10420746
[TBL] [Abstract][Full Text] [Related]
18. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
McMurray JJ; Pitt B; Latini R; Maggioni AP; Solomon SD; Keefe DL; Ford J; Verma A; Lewsey J;
Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266
[TBL] [Abstract][Full Text] [Related]
19. [Parameters of vasomotor function of endothelium and elasticity of arterial wall during therapy with angiotensin converting enzyme inhibitor ramiprilin patients with type 2 diabetes mellitus].
Vikulova OK; Iarek-Martynova IR; Trubitsina NP; Shestakova MV
Kardiologiia; 2008; 48(11):47-52. PubMed ID: 19076080
[No Abstract] [Full Text] [Related]
20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
